Evidence map›Paper›PMID 37377964›Full record

ArticleFrontiers in immunology2023

Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines.

Shanti Pather, Shabir A Madhi, Benjamin J Cowling, Paul Moss, Jeremy P Kamil, Sandra Ciesek, Alexander Muik, Özlem Türeci

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Shanti PatherBioNTech, Mainz, Germany.
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Benjamin J CowlingSchool of Public Health, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Paul MossInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Jeremy P KamilDepartment of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, LA, United States.
Sandra CiesekInstitute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.
Alexander MuikBioNTech, Mainz, Germany.
Özlem TüreciBioNTech, Mainz, Germany.

Funding

Medical Research Council MC_PC_20031Medical Research Council MC_PC_20060
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1130539.].

Indexed as

BA.1disease burdenOmicronsub-lineagevaccine

Identifiers

PMID37377964
PMCPMC10292686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.